Home / Octreotide / Sweden
SE ATC H01CB02 · updated 2 Nov 2026
Octreotide shortage in Sweden
Is there an Octreotide shortage in Sweden?
Yes. As of 2 Nov 2026, 6 Octreotide products are reported short in Sweden, the first since 2 Jan 2025. The company estimate for the return is 6 Nov 2026 (latest 30 Jun 2028). Main reason: not stated.
Also short in Canada, Italy, Spain, Austria, Japan. All countries.
Affected products in Sweden
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| SE | Octreotide Teva 30 mg Injektionsflaska + förfylld spruta, 1 x (30 mg + 2 ml) (med flaskadapter) | Teva B.V. | 2 Jan 2025 | 30 Jun 2028 | Not stated |
| SE | Oktreotid SUN 200 mikrogram/ml Injektionsflaska, 1 x 5 ml | Sun Pharmaceutical Industries Europe B.V. | 31 Dec 2025 | 13 Nov 2026 | Not stated |
| SE | Octreotide Teva 20 mg Injektionsflaska + förfylld spruta, 1 x (20 mg + 2 ml) (med flaskadapter) | Teva B.V. | 1 May 2026 | 30 Jun 2028 | Not stated |
| SE | Octreotide Teva 10 mg Injektionsflaska + förfylld spruta, 1 x (10 mg + 2 ml) (med flaskadapter) | Teva B.V. | 10 May 2026 | 30 Jun 2028 | Not stated |
| SE | Oktreotid SUN 50 mikrogram/ml Ampull, 5 x 1 ml | Sun Pharmaceutical Industries Europe B.V. | 12 Aug 2026 | 8 Mar 2027 | Not stated |
| SE | Oktreotid SUN 500 mikrogram/ml Ampull, 5 x 1 ml | Sun Pharmaceutical Industries Europe B.V. | 12 Aug 2026 | 6 Nov 2026 | Not stated |
Source
Läkemedelsverket (Swedish Medical Products Agency). Official list. Ongoing and announced shortages (restanmälningar) reported by companies; one row per pack.